CatalystPit
TerminalPit ConsensusInsidersPoliticiansInstitutionsNewsScreener

INBXInhibrx Biosciences, Inc.

NASDAQ · BIOLOGICAL PRODUCTS, (NO DIAGNOSTIC SUBSTANCES)
Last close $100.08 · 2026-09-30
ABOUT
ExchangeNASDAQ
SectorHealthcare
IndustryBIOLOGICAL PRODUCTS, (NO DIAGNOSTIC SUBSTANCES)
Market cap$1.47B
CountryUSA
RECENT INSIDER TRADES
  • 2026-09-28 · Lappe Mark (Chief Executive Officer) · BUY
  • 2026-09-23 · Kayyem Jon Faiz (Director) · BUY
INSTITUTIONAL OWNERSHIP
Institutional holders171
Shares held15,784,633
Value$1.42B
Percent of shares outstanding107.25%
As of quarter end2026-06-30
RECENT NEWS
  • Inhibrx Biosciences CEO Mark Lappe buys $998k in company stock
  • Inhibrx Biosciences director Jon Kayyem buys $500,000 in stock
  • Inhibrx Biosciences, Inc. · 8-K (7.01,8.01,9.01)
CatalystPit
FeaturesComing soonPricingComing soonPrivacyTermsDisclaimerAffiliate TermsContact
2026 CATALYSTPIT · NOT FINANCIAL ADVICE · DELAYED FILINGS